[53] In the other three trials (NCT3987919, NCT03882970, and NCT03730662), participants were randomly assigned to receive either tirzepatide or another antidiabetic medication, and both the patient and the provider knew which medication was being given
If you have any information regarding this or similar illegal products, please report it directly to the Enforcement Section of the Federal Office for Safety in Health Care at [email protected].
Congress passed a bill in the 1990s prohibiting Medicare part-B from covering cosmetic treatments, which has prevented it from covering drugs prescribed solely for weight loss, though it does cover GLP-1s in some cases for heart disease, according to Joseph Levy, an assistant professor of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health
Zepbound is made by Eli Lilly and Company and contains the active ingredient tirzepatide, while Ozempic is made by Novo Nordisk and contains the active ingredient semaglutide